Form 144

144: Filer Information

Filer CIK

0001310611

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

CAPRICOR THERAPEUTICS, INC.

SEC File Number

001-34058

Address of Issuer

10865 ROAD TO THE CURE
SUITE 150
SAN DIEGO
CALIFORNIA
92121

Phone

(310) 358-3200

Name of Person for Whose Account the Securities are To Be Sold

Musket David B

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	88788	2397256.00	57911893	05/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/21/2015	Purchase	Open Market	7096	01/21/2015	Cash/ check
Common	08/07/2024	Stock Award	Issuer	34000	08/07/2024	Compensation
Common	04/23/2024	Stock Award	Issuer	16156	04/23/2024	Compensation
Common	10/12/2023	Purchase	Open Market	410	10/12/2023	Cash
Common	10/09/2023	Purchase	Open Market	5083	10/09/2023	Cash
Common	10/04/2023	Purchase	Open Market	2500	10/04/2023	Cash
Common	06/30/2022	Stock Award	Issuer	10796	06/30/2022	Compensation
Common	12/27/2021	Stock Award	Issuer	12747	12/27/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

7,096 out of his IRA and 81,692 out of his individual

Date of Notice

05/19/2026

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Cristina Garcia, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Musket David B

FORM 144